Kevin J Kim

Title: Kevin J Kim: Innovator in Pharmaceutical Compositions

Introduction

Kevin J Kim is a notable inventor based in Menlo Park, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in developing methods to counteract the cardiotoxic effects of chemotherapy. With a total of 4 patents to his name, Kim's work is paving the way for safer cancer treatments.

Latest Patents

One of Kim's latest patents focuses on pharmaceutical compositions and methods for countering chemotherapy-induced cardiotoxicity. This disclosure provides innovative methods and compositions aimed at reducing or eliminating cardiotoxicity, especially that induced by cancer treatments. The methods often involve administering protective agents such as myricetin, tricetin, robinetin, ficetin, vitexin, quercetin, dihydrorobinetin, kaempferol, and others in conjunction with cancer drugs. These compositions may also include co-formulations of protective agents with anthracycline drugs, enhancing the safety and efficacy of cancer therapies.

Career Highlights

Throughout his career, Kevin J Kim has worked with various companies, including Auransa Inc. and Sct II LLC. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and research.

Collaborations

Kim has collaborated with notable professionals in his field, including Christopher G Armstrong and Lisa Maria Lucia Pham. These collaborations have further enriched his research and development efforts.

Conclusion

Kevin J Kim is a distinguished inventor whose work in pharmaceutical compositions is making a significant impact on cancer treatment safety. His innovative approaches are essential for advancing medical science and improving patient outcomes.